{"gene":"MCM9","run_date":"2026-06-10T02:59:50","timeline":{"discoveries":[{"year":2008,"finding":"MCM9 binds to chromatin in an ORC-dependent manner and forms a stable complex with the licensing factor Cdt1, preventing excess geminin on chromatin during the licensing reaction; MCM9 is required for recruitment of the MCM2-7 helicase onto chromatin and pre-RC assembly, acting as an essential activating linker between Cdt1 and the MCM2-7 complex.","method":"Xenopus egg extract system; chromatin fractionation; depletion/add-back experiments; co-immunoprecipitation","journal":"Molecular cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical reconstitution in egg extract with depletion, chromatin fractionation, and Co-IP in a single lab; later contradicted by Gambus & Blow 2013 in the same system","pmids":["18657502"],"is_preprint":false},{"year":2012,"finding":"MCM8 and MCM9 form a complex and co-regulate each other's stability; loss of either gene impairs chromatin recruitment of HR factors RAD51 and RPA, strongly reduces homologous recombination, and prevents cells from overcoming transient inhibition of replication fork progression.","method":"Knockout mouse embryonic fibroblasts; co-immunoprecipitation; chromatin recruitment assays; HR reporter assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with defined cellular phenotype, reciprocal Co-IP, and HR assays; independently replicated across multiple labs (PMIDs 22771120 and 22771115)","pmids":["22771120","22771115"],"is_preprint":false},{"year":2012,"finding":"MCM8 and MCM9 form a complex required for HR repair induced by DNA interstrand crosslinks (ICLs); in DT40 cells lacking MCM8 or MCM9, RAD51 foci partially colocalize with MCM8-MCM9 foci; MCM8-9 works downstream of the FA pathway and BRCA2/RAD51, likely as a hexameric ATPase/helicase, to promote sister chromatid exchanges.","method":"Chicken DT40 knockout cells; immunofluorescence; epistasis analysis with FA/BRCA2 pathway mutants; ICL sensitivity assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis in DT40 cells with multiple ICL agents, co-localization with RAD51, pathway placement downstream of FA/BRCA2; independently corroborated by PMID 22771120","pmids":["22771115"],"is_preprint":false},{"year":2013,"finding":"MCM8 and MCM9 physically associate, MCM8 is required for stability of MCM9 protein; both proteins are rapidly recruited to DNA damage sites and promote RAD51 recruitment there; depletion of MCM8 or MCM9 significantly reduces HR repair efficiency and sensitizes cells to ICL agents.","method":"Co-immunoprecipitation in mammalian cells; chromatin immunoprecipitation (ChIP) in human DR-GFP cells and Xenopus egg extract; HR reporter assay; cisplatin sensitivity assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, ChIP at damage sites, HR reporter assay, and cisplatin sensitivity in multiple cell systems; consistent with independent reports","pmids":["23401855"],"is_preprint":false},{"year":2013,"finding":"In Xenopus egg extract, MCM8 and MCM9 form a dimeric complex (not a role in Cdt1-dependent MCM2-7 loading); they associate with chromatin at later stages of DNA replication, and this association is stimulated by DNA damage, suggesting their primary function is in DNA repair analogous to that in somatic cells.","method":"Xenopus egg extract; gel filtration; chromatin fractionation; DNA damage stimulation assay; no interaction with Cdt1 detected (negative result for pre-RC role)","journal":"Cell cycle","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical reconstitution in egg extract with multiple methods; directly contradicts the earlier Lutzmann/Méchali 2008 pre-RC loading claim in the same system","pmids":["23518502"],"is_preprint":false},{"year":2015,"finding":"MCM9 forms a complex with MMR initiation proteins MSH2, MSH3, MLH1, PMS1, and the clamp loader RFC; MCM9 helicase activity is required for efficient mismatch repair (MMR), as wild-type but not helicase-dead MCM9 restores MMR in Mcm9−/− cells; MCM9 loading onto chromatin is MSH2-dependent, and MCM9 in turn stimulates recruitment of MLH1 to chromatin; Mcm9−/− cells display microsatellite instability.","method":"Mcm9 knockout cells; co-immunoprecipitation; helicase-dead point mutant rescue experiments; microsatellite instability assay; chromatin recruitment assay","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — knockout combined with helicase-dead mutagenesis rescue, Co-IP of complex, chromatin loading assay, and functional MMR assay in a single study","pmids":["26300262"],"is_preprint":false},{"year":2005,"finding":"MCM9 is a vertebrate-specific MCM family member containing an MCM8-like ATP-binding and hydrolysis motif implicated in helicase activity, plus a unique carboxy-terminal domain conserved only in MCM9 homologs; it is most closely related to MCM8 and does not group with MCM2-7.","method":"Bioinformatics/sequence analysis; phylogenetic analysis; domain identification","journal":"Gene","confidence":"Low","confidence_rationale":"Tier 4 / Moderate — computational sequence analysis only, no direct biochemical validation of helicase activity in this paper","pmids":["16226853"],"is_preprint":false},{"year":2011,"finding":"Ablation of Mcm9 in mice is compatible with cell proliferation and viability, showing MCM9 is nonessential for MCM2-7 loading or bulk DNA replication; however, MCM9-deficient cells show elevated genomic instability and defective cell cycle re-entry following replication stress, and MCM9 is required for germ-line stem cell maintenance and tumor suppression.","method":"Conditional/constitutive knockout mice; cell proliferation assays; replication stress (HU) challenge; genomic instability assays","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout in mice with defined cellular and organismal phenotypes; directly tests and rules out the pre-RC loading role in vivo","pmids":["21987787"],"is_preprint":false},{"year":2014,"finding":"A human MCM9 splice-site variant (c.1732+2T>C) produces truncated MCM9 forms that are unable to be recruited to sites of DNA damage, resulting in impaired chromosomal break repair in patient lymphocytes; a second nonsense variant (p.Arg132*) causes loss of functional MCM9 and the same DNA repair defect, establishing that MCM9 recruitment to damage sites is required for HR-mediated repair.","method":"Patient lymphocyte DNA repair assay; splicing analysis; immunofluorescence for MCM9 recruitment to damage sites","journal":"American journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct functional assay in patient cells showing impaired recruitment and DNA repair; single study","pmids":["25480036"],"is_preprint":false},{"year":2019,"finding":"HROB (C17orf53) is an OB-fold-containing factor that recruits the MCM8-MCM9 helicase to sites of DNA damage to promote recombination-associated DNA synthesis; the HROB-MCM8-MCM9 pathway acts redundantly with the HELQ helicase downstream of RAD51, and combined loss of HROB and HELQ severely impairs HR.","method":"Genetic epistasis in mouse knockout models; foci co-localization; HR assays; infertility phenotype analysis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with double mutants, functional HR assays, in vivo mouse phenotype; pathway placement of MCM8-MCM9 downstream of RAD51 via HROB loader","pmids":["31467087"],"is_preprint":false},{"year":2020,"finding":"HORMAD1 interacts with the MCM8-MCM9 complex and prevents its efficient nuclear localization; as a consequence, HORMAD1-expressing cancer cells have reduced MLH1 chromatin binding and MMR defects.","method":"Co-immunoprecipitation; nuclear/cytoplasmic fractionation; immunofluorescence; MLH1 chromatin binding assay","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP of interaction, fractionation showing mislocalization, and functional MMR consequence; single lab","pmids":["32647118"],"is_preprint":false},{"year":2021,"finding":"The MCM9 C-terminal extension (CTE) contains a bipartite-like NLS required for nuclear import of both MCM8 and MCM9, and a variant BRC motif (BRCv) necessary for localization to MMC-induced damage sites; the MCM9-BRCv directly interacts with RAD51 and recruits it downstream to MMC-induced damage; cells lacking functional MCM9 have significantly impaired RAD51 foci formation after MMC treatment.","method":"Domain deletion and point mutant analysis; immunofluorescence of damage foci; co-immunoprecipitation of MCM9-BRCv with RAD51; patient lymphocyte and MCM9 KO cell assays","journal":"Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — mutagenesis of specific motifs, Co-IP of RAD51 interaction, functional foci assay in multiple cell systems including patient lymphocytes; multiple orthogonal methods","pmids":["33539926"],"is_preprint":false},{"year":2013,"finding":"MCM9 exists as two isoforms (MCM9L and MCM9M) generated by alternative splicing; both are cell cycle regulated (induced in S-phase, decreased in G2/M); MCM9L expression is specifically induced by mitomycin C (ICL damage) but not by hydroxyurea (replication fork stalling), consistent with a specific role in ICL/HR repair rather than general replication.","method":"qRT-PCR of isoforms across cell lines; cell cycle synchronization; drug treatment (MMC vs. HU)","journal":"Gene","confidence":"Low","confidence_rationale":"Tier 3 / Moderate — expression-level evidence only, no direct protein functional assay; consistent with other mechanistic findings","pmids":["23403237"],"is_preprint":false},{"year":2015,"finding":"MCM9 deficiency causes reduced primordial germ cell (PGC) proliferation (not apoptosis) through a mechanism independent of the ATM-CHK2-TRP53-P21 signaling pathway; germ cell depletion in Mcm9 and Fancm double-mutant mice is additive, indicating that MCM9 and FANCM deficiency trigger different DDR pathways.","method":"Mouse knockout genetics; PGC counting; apoptosis assays; genetic epistasis with ATM/p53 pathway mutants and Fancm mutants","journal":"Genesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis in double-mutant mice with quantitative PGC and apoptosis readouts; single lab","pmids":["26388201"],"is_preprint":false},{"year":2025,"finding":"In human testicular cells, MCM9 interacts with both MSH2 and MLH1, confirming involvement of the MCM9-mediated MMR pathway in maintaining genomic integrity in spermatogonial stem cells; MCM9 is predominantly expressed in spermatogonial stem cells and spermatogonia in human testes.","method":"Co-immunoprecipitation in human testicular tissue; immunohistochemistry/immunofluorescence for cell-type-specific expression; HEK293T knockout and mutant overexpression HR assay","journal":"Cell death discovery","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP of MCM9-MSH2/MLH1 interaction in human tissue and functional HR assay in KO cells; single study","pmids":["40593474"],"is_preprint":false},{"year":2025,"finding":"MCM8/9 physically interacts with FANCD2 through the MCM8/9 core domain, independently of DNA; FANCD2 is essential for recruitment of MCM9 to ICL-induced nuclear foci, acting downstream of FANCD2 monoubiquitination; combined loss of MCM9 and FANCD2 is epistatic (no additive DNA damage), placing MCM8/9 as a downstream effector within the FA pathway for ICL repair.","method":"Co-immunoprecipitation; immunofluorescence of damage foci; MCM8/9 knockout cells; epistasis analysis by γH2AX and cell survival assays","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, foci analysis, epistasis by double KO; preprint, not yet peer-reviewed","pmids":["bio_10.1101_2025.08.07.669127"],"is_preprint":true}],"current_model":"MCM9 forms a heteromeric complex with MCM8, stabilizes each other, and together function as a helicase/ATPase recruited to DNA damage sites (ICLs, DSBs) via an HROB loader and via MCM9's C-terminal BRCv motif that directly binds RAD51 to promote recombination-associated DNA synthesis downstream of the FA pathway and RAD51; MCM9 also forms a complex with MMR proteins (MSH2, MSH3, MLH1, PMS1, RFC), and its intrinsic helicase activity is required for mismatch repair; MCM9 is dispensable for bulk DNA replication in vivo but is essential for germ cell development, genome stability, and tumor suppression."},"narrative":{"mechanistic_narrative":"MCM9 is a vertebrate-specific MCM-family ATPase/helicase that operates principally in DNA repair and the maintenance of genome stability rather than in bulk DNA replication [PMID:21987787, PMID:22771120, PMID:22771115]. It forms an obligate heteromeric complex with MCM8 in which the two subunits reciprocally stabilize each other, and this MCM8-MCM9 complex is rapidly recruited to DNA damage sites where it promotes loading of RPA and RAD51 to drive homologous recombination [PMID:22771120, PMID:22771115, PMID:23401855]. The complex acts downstream of the Fanconi anemia pathway and BRCA2/RAD51 to repair DNA interstrand crosslinks and to support recombination-associated DNA synthesis, with recruitment mediated by the OB-fold loader HROB and acting redundantly with the HELQ helicase [PMID:22771115, PMID:31467087]. MCM9 contributes its own recruitment and effector functions: a C-terminal extension carries an NLS required for nuclear import of both MCM8 and MCM9 and a variant BRC (BRCv) motif that directly binds RAD51 and recruits it to crosslink-induced damage [PMID:33539926]. Independently of recombination, MCM9 assembles with mismatch repair initiation factors MSH2, MSH3, MLH1, PMS1 and the clamp loader RFC, and its intrinsic helicase activity is required for efficient mismatch repair; MCM9 chromatin loading is MSH2-dependent and in turn stimulates MLH1 recruitment, with loss causing microsatellite instability [PMID:26300262]. These activities make MCM9 dispensable for cell viability but essential for germ cell development, genome stability, and tumor suppression, and loss-of-function variants in patients impair recruitment to damage sites and chromosomal break repair [PMID:21987787, PMID:25480036].","teleology":[{"year":2008,"claim":"The first functional study tested whether MCM9 participates in replication licensing, proposing it as an activating linker coupling Cdt1 to MCM2-7 loading.","evidence":"Xenopus egg extract depletion/add-back with chromatin fractionation and Co-IP","pmids":["18657502"],"confidence":"Medium","gaps":["Single-system biochemical claim later contradicted in the same extract system","No in vivo test of the proposed pre-RC role"]},{"year":2011,"claim":"Genetic knockout in mice directly tested the replication-licensing hypothesis and instead established MCM9 as nonessential for bulk replication but required for genome stability, germ-line maintenance, and tumor suppression.","evidence":"Constitutive/conditional knockout mice with proliferation, replication-stress, and genomic instability assays","pmids":["21987787"],"confidence":"High","gaps":["Molecular mechanism of the genome-instability and germ-cell phenotype not resolved here","Did not identify direct repair partners"]},{"year":2012,"claim":"Independent knockout studies defined the MCM8-MCM9 heterocomplex as a homologous recombination factor that reciprocally stabilizes its subunits and is needed for RAD51/RPA loading and ICL repair.","evidence":"Knockout MEFs and DT40 cells with reciprocal Co-IP, chromatin recruitment, HR reporter, and FA/BRCA2 epistasis analysis","pmids":["22771120","22771115"],"confidence":"High","gaps":["How the complex is recruited to damage sites unknown","Helicase/ATPase activity inferred rather than directly reconstituted"]},{"year":2013,"claim":"Mammalian and Xenopus studies confirmed the physical interaction, MCM8-dependent MCM9 stability, and damage-site recruitment, while a parallel egg-extract study refuted the earlier pre-RC loading role.","evidence":"Co-IP, ChIP at damage sites, HR reporter and cisplatin assays; gel filtration and chromatin fractionation in Xenopus extract","pmids":["23401855","23518502"],"confidence":"High","gaps":["Reconciliation of the two conflicting egg-extract reports incomplete","Recruitment factor still unidentified"]},{"year":2015,"claim":"A second, recombination-independent function was established: MCM9 helicase activity is required for mismatch repair within a complex containing MSH2/MSH3/MLH1/PMS1/RFC.","evidence":"Mcm9 knockout cells with helicase-dead rescue, Co-IP, chromatin loading and microsatellite instability assays","pmids":["26300262"],"confidence":"High","gaps":["DNA substrate unwound during MMR not defined","How MCM9 partitions between MMR and HR roles unclear"]},{"year":2014,"claim":"Patient loss-of-function variants demonstrated that recruitment of MCM9 to damage sites is required for chromosomal break repair in humans.","evidence":"Patient lymphocyte DNA repair assay, splicing analysis, and immunofluorescence for MCM9 recruitment","pmids":["25480036"],"confidence":"Medium","gaps":["Single study","Did not define the molecular determinant of recruitment"]},{"year":2019,"claim":"The recruitment problem was solved by identifying HROB as an OB-fold loader that brings MCM8-MCM9 to damage, acting downstream of RAD51 redundantly with HELQ.","evidence":"Mouse knockout genetic epistasis with double mutants, foci colocalization, HR assays, and infertility phenotyping","pmids":["31467087"],"confidence":"High","gaps":["Structural basis of HROB-MCM8/9 engagement unknown","Division of labor between HELQ and MCM8/9 branches not fully mapped"]},{"year":2021,"claim":"Domain mapping resolved how MCM9 itself contributes to nuclear import and RAD51 recruitment, identifying an NLS and a RAD51-binding BRCv motif in its C-terminal extension.","evidence":"Domain deletion/point mutants, damage-foci immunofluorescence, Co-IP of MCM9-BRCv with RAD51 in multiple cell systems","pmids":["33539926"],"confidence":"High","gaps":["Structure of the BRCv-RAD51 interface not determined","Relationship between BRCv-mediated and HROB-mediated recruitment unresolved"]},{"year":2020,"claim":"Regulation of the complex was probed by showing HORMAD1 sequesters MCM8-MCM9 in the cytoplasm, linking aberrant expression to MMR defects in cancer.","evidence":"Co-IP, nuclear/cytoplasmic fractionation, immunofluorescence, and MLH1 chromatin binding assay","pmids":["32647118"],"confidence":"Medium","gaps":["Single lab","Generality across tumor types not tested"]},{"year":2025,"claim":"The MMR-associated role of MCM9 was extended to human spermatogonial stem cells, tying its interactions with MSH2 and MLH1 to germ-line genome integrity.","evidence":"Co-IP in human testicular tissue, cell-type-specific immunostaining, and HR assay in knockout HEK293T cells","pmids":["40593474"],"confidence":"Medium","gaps":["Single study","Causal link between MMR defect and human fertility outcomes not established"]},{"year":2025,"claim":"A direct FANCD2-MCM8/9 interaction was reported, placing the complex as a downstream effector of FANCD2 monoubiquitination in ICL repair.","evidence":"Co-IP, damage-foci immunofluorescence, and double-knockout epistasis (preprint)","pmids":["bio_10.1101_2025.08.07.669127"],"confidence":"Medium","gaps":["Preprint, not yet peer-reviewed","Direct binding interface and dependence on DNA require validation"]},{"year":null,"claim":"How MCM9 mechanistically partitions between its HR/ICL-repair and mismatch-repair functions, and the precise DNA substrates its helicase activity acts upon in each pathway, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No reconstituted helicase reaction defining physiological substrate","No structure of the MCM8-MCM9 complex bound to DNA or partners","Mechanism choosing between MMR and HR engagement unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[2,5]},{"term_id":"GO:0140097","term_label":"catalytic activity, acting on DNA","supporting_discovery_ids":[5]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[1,3]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[11,5]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[11,10]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[1,3,5]}],"pathway":[{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[1,2,3,5,9]},{"term_id":"R-HSA-1474165","term_label":"Reproduction","supporting_discovery_ids":[7,9,13,14]}],"complexes":["MCM8-MCM9 helicase complex"],"partners":["MCM8","RAD51","HROB","MSH2","MLH1","FANCD2","HORMAD1","RFC"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9NXL9","full_name":"DNA helicase MCM9","aliases":["DNA 3'-5' helicase MCM9","Mini-chromosome maintenance deficient domain-containing protein 1","Minichromosome maintenance 9"],"length_aa":1143,"mass_kda":127.3,"function":"Component of the MCM8-MCM9 complex, which is involved in the repair of double-stranded DNA breaks (DBSs) and DNA interstrand cross-links (ICLs) by homologous recombination (HR) (PubMed:23401855). The MCM8-MCM9 complex is a 3'-5' DNA helicase and single-stranded (ss)DNA-stimulated ATPase which binds ssDNA in the presence of nucleoside triphosphates (PubMed:37309874). Required for DNA resection by the MRE11-RAD50-NBN/NBS1 (MRN) complex by recruiting the MRN complex to the repair site and by promoting the complex nuclease activity (PubMed:26215093). Indirectly regulates the recruitment of downstream effector RAD51 to DNA damage sites including DBSs and ICLs, probably by regulating the localization of the MNR complex (PubMed:23401855). Acts as a helicase in DNA mismatch repair (MMR) following DNA replication errors to unwind the mismatch containing DNA strand (PubMed:26300262). In addition, recruits MLH1, a component of the MMR complex, to chromatin (PubMed:26300262). The MCM8-MCM9 complex is dispensable for DNA replication and S phase progression (PubMed:23401855). Plays a key role during gametogenesis, probably by regulating HR (By similarity)","subcellular_location":"Nucleus; Chromosome","url":"https://www.uniprot.org/uniprotkb/Q9NXL9/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MCM9","classification":"Not Classified","n_dependent_lines":29,"n_total_lines":1208,"dependency_fraction":0.024006622516556293},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"MSH6","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/MCM9","total_profiled":1310},"omim":[{"mim_id":"620897","title":"OVARIAN DYSGENESIS 11; ODG11","url":"https://www.omim.org/entry/620897"},{"mim_id":"618611","title":"HOMOLOGOUS RECOMBINATION FACTOR WITH OB-FOLD; HROB","url":"https://www.omim.org/entry/618611"},{"mim_id":"616185","title":"OVARIAN DYSGENESIS 4; ODG4","url":"https://www.omim.org/entry/616185"},{"mim_id":"610098","title":"MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 9; MCM9","url":"https://www.omim.org/entry/610098"},{"mim_id":"608187","title":"MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 8; MCM8","url":"https://www.omim.org/entry/608187"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/MCM9"},"hgnc":{"alias_symbol":["MGC35304","dJ329L24.3","FLJ20170"],"prev_symbol":["MCMDC1","C6orf61"]},"alphafold":{"accession":"Q9NXL9","domains":[{"cath_id":"3.30.1640.10","chopping":"2-103","consensus_level":"medium","plddt":83.0458,"start":2,"end":103},{"cath_id":"2.40.50","chopping":"113-235_258-270","consensus_level":"medium","plddt":82.6315,"start":113,"end":270}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NXL9","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NXL9-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NXL9-F1-predicted_aligned_error_v6.png","plddt_mean":61.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MCM9","jax_strain_url":"https://www.jax.org/strain/search?query=MCM9"},"sequence":{"accession":"Q9NXL9","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9NXL9.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9NXL9/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NXL9"}},"corpus_meta":[{"pmid":"22771120","id":"PMC_22771120","title":"MCM8- and MCM9-deficient mice reveal gametogenesis defects and genome instability due to impaired homologous recombination.","date":"2012","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/22771120","citation_count":178,"is_preprint":false},{"pmid":"25480036","id":"PMC_25480036","title":"MCM9 mutations are associated with ovarian failure, short stature, and chromosomal instability.","date":"2014","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25480036","citation_count":161,"is_preprint":false},{"pmid":"22771115","id":"PMC_22771115","title":"Mcm8 and Mcm9 form a complex that functions in homologous recombination repair induced by DNA interstrand crosslinks.","date":"2012","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/22771115","citation_count":126,"is_preprint":false},{"pmid":"23401855","id":"PMC_23401855","title":"The MCM8-MCM9 complex promotes RAD51 recruitment at DNA damage sites to facilitate homologous recombination.","date":"2013","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/23401855","citation_count":114,"is_preprint":false},{"pmid":"27802094","id":"PMC_27802094","title":"MCM8 and MCM9 Nucleotide Variants in Women With Primary Ovarian Insufficiency.","date":"2017","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/27802094","citation_count":90,"is_preprint":false},{"pmid":"21987787","id":"PMC_21987787","title":"Minichromosome maintenance helicase paralog MCM9 is dispensible for DNA replication but functions in germ-line stem cells and tumor suppression.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/21987787","citation_count":74,"is_preprint":false},{"pmid":"31467087","id":"PMC_31467087","title":"Control of homologous recombination by the HROB-MCM8-MCM9 pathway.","date":"2019","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/31467087","citation_count":66,"is_preprint":false},{"pmid":"18657502","id":"PMC_18657502","title":"MCM9 binds Cdt1 and is required for the assembly of prereplication complexes.","date":"2008","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/18657502","citation_count":65,"is_preprint":false},{"pmid":"26300262","id":"PMC_26300262","title":"MCM9 Is Required for Mammalian DNA Mismatch Repair.","date":"2015","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/26300262","citation_count":62,"is_preprint":false},{"pmid":"26771056","id":"PMC_26771056","title":"A non-sense MCM9 mutation in a familial case of primary ovarian insufficiency.","date":"2016","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26771056","citation_count":61,"is_preprint":false},{"pmid":"26806154","id":"PMC_26806154","title":"Mutated MCM9 is associated with predisposition to hereditary mixed polyposis and colorectal cancer in addition to primary ovarian failure.","date":"2015","source":"Cancer genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26806154","citation_count":49,"is_preprint":false},{"pmid":"16226853","id":"PMC_16226853","title":"Identification of full genes and proteins of MCM9, a novel, vertebrate-specific member of the MCM2-8 protein family.","date":"2005","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/16226853","citation_count":46,"is_preprint":false},{"pmid":"15850810","id":"PMC_15850810","title":"Identification of a novel cell-cycle-induced MCM family protein MCM9.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15850810","citation_count":45,"is_preprint":false},{"pmid":"32647118","id":"PMC_32647118","title":"Aberrantly expressed HORMAD1 disrupts nuclear localization of MCM8-MCM9 complex and compromises DNA mismatch repair in cancer cells.","date":"2020","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/32647118","citation_count":40,"is_preprint":false},{"pmid":"31509747","id":"PMC_31509747","title":"MCM8- and MCM9 Deficiencies Cause Lifelong Increased Hematopoietic DNA Damage Driving p53-Dependent Myeloid Tumors.","date":"2019","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/31509747","citation_count":31,"is_preprint":false},{"pmid":"32145932","id":"PMC_32145932","title":"Novel pathogenic mutations in minichromosome maintenance complex component 9 (MCM9) responsible for premature ovarian insufficiency.","date":"2020","source":"Fertility and sterility","url":"https://pubmed.ncbi.nlm.nih.gov/32145932","citation_count":28,"is_preprint":false},{"pmid":"23518502","id":"PMC_23518502","title":"Mcm8 and Mcm9 form a dimeric complex in Xenopus laevis egg extract that is not essential for DNA replication initiation.","date":"2013","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/23518502","citation_count":26,"is_preprint":false},{"pmid":"33539926","id":"PMC_33539926","title":"Motifs of the C-terminal domain of MCM9 direct localization to sites of mitomycin-C damage for RAD51 recruitment.","date":"2021","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33539926","citation_count":24,"is_preprint":false},{"pmid":"26388201","id":"PMC_26388201","title":"MCM9 deficiency delays primordial germ cell proliferation independent of the ATM pathway.","date":"2015","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/26388201","citation_count":22,"is_preprint":false},{"pmid":"37378315","id":"PMC_37378315","title":"Molecular functions of MCM8 and MCM9 and their associated pathologies.","date":"2023","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/37378315","citation_count":19,"is_preprint":false},{"pmid":"33750944","id":"PMC_33750944","title":"The etiology of Down syndrome: Maternal MCM9 polymorphisms increase risk of reduced recombination and nondisjunction of chromosome 21 during meiosis I within oocyte.","date":"2021","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33750944","citation_count":13,"is_preprint":false},{"pmid":"34556653","id":"PMC_34556653","title":"MCM9 is associated with germline predisposition to early-onset cancer-clinical evidence.","date":"2021","source":"NPJ genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34556653","citation_count":12,"is_preprint":false},{"pmid":"23403237","id":"PMC_23403237","title":"Identification, quantification, and evolutionary analysis of a novel isoform of MCM9.","date":"2013","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/23403237","citation_count":9,"is_preprint":false},{"pmid":"27886675","id":"PMC_27886675","title":"Pathogenic germline MCM9 variants are rare in Australian Lynch-like syndrome patients.","date":"2016","source":"Cancer genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27886675","citation_count":8,"is_preprint":false},{"pmid":"36769638","id":"PMC_36769638","title":"The Role of MCM9 in the Etiology of Sertoli Cell-Only Syndrome and Premature Ovarian Insufficiency.","date":"2023","source":"Journal of clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36769638","citation_count":7,"is_preprint":false},{"pmid":"26870752","id":"PMC_26870752","title":"Proteomic data on the nuclear interactome of human MCM9.","date":"2015","source":"Data in brief","url":"https://pubmed.ncbi.nlm.nih.gov/26870752","citation_count":5,"is_preprint":false},{"pmid":"39447595","id":"PMC_39447595","title":"MCM9 compound heterozygosity in an adolescent with premature ovarian insufficiency.","date":"2024","source":"Endocrinology, diabetes & metabolism case reports","url":"https://pubmed.ncbi.nlm.nih.gov/39447595","citation_count":2,"is_preprint":false},{"pmid":"40593474","id":"PMC_40593474","title":"MCM9 deficiency impairs DNA damage repair during spermatogenesis, leading to Sertoli cell-only syndrome in humans.","date":"2025","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/40593474","citation_count":1,"is_preprint":false},{"pmid":"40684266","id":"PMC_40684266","title":"Clinical syndromes linked to biallelic germline variants in MCM8 and MCM9.","date":"2025","source":"HGG advances","url":"https://pubmed.ncbi.nlm.nih.gov/40684266","citation_count":1,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.08.07.669127","title":"MCM8/9 and FANCD2 interact within a shared pathway in response to replication stress caused by DNA crosslinks","date":"2025-08-07","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.07.669127","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.10.30.24315828","title":"Clinical syndromes linked to biallelic germline variants in<i>MCM8</i>and<i>MCM9</i>","date":"2024-11-04","source":"bioRxiv","url":"https://doi.org/10.1101/2024.10.30.24315828","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":16118,"output_tokens":4124,"usd":0.055107,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":12051,"output_tokens":3628,"usd":0.075478,"stage2_stop_reason":"end_turn"},"total_usd":0.130585,"stage1_batch_id":"msgbatch_01BbTCMyrRPyhtEq6b1MdwCN","stage2_batch_id":"msgbatch_011dEed5bbxYvTAaQWKJevxu","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2008,\n      \"finding\": \"MCM9 binds to chromatin in an ORC-dependent manner and forms a stable complex with the licensing factor Cdt1, preventing excess geminin on chromatin during the licensing reaction; MCM9 is required for recruitment of the MCM2-7 helicase onto chromatin and pre-RC assembly, acting as an essential activating linker between Cdt1 and the MCM2-7 complex.\",\n      \"method\": \"Xenopus egg extract system; chromatin fractionation; depletion/add-back experiments; co-immunoprecipitation\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical reconstitution in egg extract with depletion, chromatin fractionation, and Co-IP in a single lab; later contradicted by Gambus & Blow 2013 in the same system\",\n      \"pmids\": [\"18657502\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"MCM8 and MCM9 form a complex and co-regulate each other's stability; loss of either gene impairs chromatin recruitment of HR factors RAD51 and RPA, strongly reduces homologous recombination, and prevents cells from overcoming transient inhibition of replication fork progression.\",\n      \"method\": \"Knockout mouse embryonic fibroblasts; co-immunoprecipitation; chromatin recruitment assays; HR reporter assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with defined cellular phenotype, reciprocal Co-IP, and HR assays; independently replicated across multiple labs (PMIDs 22771120 and 22771115)\",\n      \"pmids\": [\"22771120\", \"22771115\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"MCM8 and MCM9 form a complex required for HR repair induced by DNA interstrand crosslinks (ICLs); in DT40 cells lacking MCM8 or MCM9, RAD51 foci partially colocalize with MCM8-MCM9 foci; MCM8-9 works downstream of the FA pathway and BRCA2/RAD51, likely as a hexameric ATPase/helicase, to promote sister chromatid exchanges.\",\n      \"method\": \"Chicken DT40 knockout cells; immunofluorescence; epistasis analysis with FA/BRCA2 pathway mutants; ICL sensitivity assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis in DT40 cells with multiple ICL agents, co-localization with RAD51, pathway placement downstream of FA/BRCA2; independently corroborated by PMID 22771120\",\n      \"pmids\": [\"22771115\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"MCM8 and MCM9 physically associate, MCM8 is required for stability of MCM9 protein; both proteins are rapidly recruited to DNA damage sites and promote RAD51 recruitment there; depletion of MCM8 or MCM9 significantly reduces HR repair efficiency and sensitizes cells to ICL agents.\",\n      \"method\": \"Co-immunoprecipitation in mammalian cells; chromatin immunoprecipitation (ChIP) in human DR-GFP cells and Xenopus egg extract; HR reporter assay; cisplatin sensitivity assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, ChIP at damage sites, HR reporter assay, and cisplatin sensitivity in multiple cell systems; consistent with independent reports\",\n      \"pmids\": [\"23401855\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"In Xenopus egg extract, MCM8 and MCM9 form a dimeric complex (not a role in Cdt1-dependent MCM2-7 loading); they associate with chromatin at later stages of DNA replication, and this association is stimulated by DNA damage, suggesting their primary function is in DNA repair analogous to that in somatic cells.\",\n      \"method\": \"Xenopus egg extract; gel filtration; chromatin fractionation; DNA damage stimulation assay; no interaction with Cdt1 detected (negative result for pre-RC role)\",\n      \"journal\": \"Cell cycle\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical reconstitution in egg extract with multiple methods; directly contradicts the earlier Lutzmann/Méchali 2008 pre-RC loading claim in the same system\",\n      \"pmids\": [\"23518502\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"MCM9 forms a complex with MMR initiation proteins MSH2, MSH3, MLH1, PMS1, and the clamp loader RFC; MCM9 helicase activity is required for efficient mismatch repair (MMR), as wild-type but not helicase-dead MCM9 restores MMR in Mcm9−/− cells; MCM9 loading onto chromatin is MSH2-dependent, and MCM9 in turn stimulates recruitment of MLH1 to chromatin; Mcm9−/− cells display microsatellite instability.\",\n      \"method\": \"Mcm9 knockout cells; co-immunoprecipitation; helicase-dead point mutant rescue experiments; microsatellite instability assay; chromatin recruitment assay\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — knockout combined with helicase-dead mutagenesis rescue, Co-IP of complex, chromatin loading assay, and functional MMR assay in a single study\",\n      \"pmids\": [\"26300262\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"MCM9 is a vertebrate-specific MCM family member containing an MCM8-like ATP-binding and hydrolysis motif implicated in helicase activity, plus a unique carboxy-terminal domain conserved only in MCM9 homologs; it is most closely related to MCM8 and does not group with MCM2-7.\",\n      \"method\": \"Bioinformatics/sequence analysis; phylogenetic analysis; domain identification\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Moderate — computational sequence analysis only, no direct biochemical validation of helicase activity in this paper\",\n      \"pmids\": [\"16226853\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Ablation of Mcm9 in mice is compatible with cell proliferation and viability, showing MCM9 is nonessential for MCM2-7 loading or bulk DNA replication; however, MCM9-deficient cells show elevated genomic instability and defective cell cycle re-entry following replication stress, and MCM9 is required for germ-line stem cell maintenance and tumor suppression.\",\n      \"method\": \"Conditional/constitutive knockout mice; cell proliferation assays; replication stress (HU) challenge; genomic instability assays\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout in mice with defined cellular and organismal phenotypes; directly tests and rules out the pre-RC loading role in vivo\",\n      \"pmids\": [\"21987787\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"A human MCM9 splice-site variant (c.1732+2T>C) produces truncated MCM9 forms that are unable to be recruited to sites of DNA damage, resulting in impaired chromosomal break repair in patient lymphocytes; a second nonsense variant (p.Arg132*) causes loss of functional MCM9 and the same DNA repair defect, establishing that MCM9 recruitment to damage sites is required for HR-mediated repair.\",\n      \"method\": \"Patient lymphocyte DNA repair assay; splicing analysis; immunofluorescence for MCM9 recruitment to damage sites\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct functional assay in patient cells showing impaired recruitment and DNA repair; single study\",\n      \"pmids\": [\"25480036\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"HROB (C17orf53) is an OB-fold-containing factor that recruits the MCM8-MCM9 helicase to sites of DNA damage to promote recombination-associated DNA synthesis; the HROB-MCM8-MCM9 pathway acts redundantly with the HELQ helicase downstream of RAD51, and combined loss of HROB and HELQ severely impairs HR.\",\n      \"method\": \"Genetic epistasis in mouse knockout models; foci co-localization; HR assays; infertility phenotype analysis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with double mutants, functional HR assays, in vivo mouse phenotype; pathway placement of MCM8-MCM9 downstream of RAD51 via HROB loader\",\n      \"pmids\": [\"31467087\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"HORMAD1 interacts with the MCM8-MCM9 complex and prevents its efficient nuclear localization; as a consequence, HORMAD1-expressing cancer cells have reduced MLH1 chromatin binding and MMR defects.\",\n      \"method\": \"Co-immunoprecipitation; nuclear/cytoplasmic fractionation; immunofluorescence; MLH1 chromatin binding assay\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP of interaction, fractionation showing mislocalization, and functional MMR consequence; single lab\",\n      \"pmids\": [\"32647118\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"The MCM9 C-terminal extension (CTE) contains a bipartite-like NLS required for nuclear import of both MCM8 and MCM9, and a variant BRC motif (BRCv) necessary for localization to MMC-induced damage sites; the MCM9-BRCv directly interacts with RAD51 and recruits it downstream to MMC-induced damage; cells lacking functional MCM9 have significantly impaired RAD51 foci formation after MMC treatment.\",\n      \"method\": \"Domain deletion and point mutant analysis; immunofluorescence of damage foci; co-immunoprecipitation of MCM9-BRCv with RAD51; patient lymphocyte and MCM9 KO cell assays\",\n      \"journal\": \"Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — mutagenesis of specific motifs, Co-IP of RAD51 interaction, functional foci assay in multiple cell systems including patient lymphocytes; multiple orthogonal methods\",\n      \"pmids\": [\"33539926\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"MCM9 exists as two isoforms (MCM9L and MCM9M) generated by alternative splicing; both are cell cycle regulated (induced in S-phase, decreased in G2/M); MCM9L expression is specifically induced by mitomycin C (ICL damage) but not by hydroxyurea (replication fork stalling), consistent with a specific role in ICL/HR repair rather than general replication.\",\n      \"method\": \"qRT-PCR of isoforms across cell lines; cell cycle synchronization; drug treatment (MMC vs. HU)\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — expression-level evidence only, no direct protein functional assay; consistent with other mechanistic findings\",\n      \"pmids\": [\"23403237\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"MCM9 deficiency causes reduced primordial germ cell (PGC) proliferation (not apoptosis) through a mechanism independent of the ATM-CHK2-TRP53-P21 signaling pathway; germ cell depletion in Mcm9 and Fancm double-mutant mice is additive, indicating that MCM9 and FANCM deficiency trigger different DDR pathways.\",\n      \"method\": \"Mouse knockout genetics; PGC counting; apoptosis assays; genetic epistasis with ATM/p53 pathway mutants and Fancm mutants\",\n      \"journal\": \"Genesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis in double-mutant mice with quantitative PGC and apoptosis readouts; single lab\",\n      \"pmids\": [\"26388201\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In human testicular cells, MCM9 interacts with both MSH2 and MLH1, confirming involvement of the MCM9-mediated MMR pathway in maintaining genomic integrity in spermatogonial stem cells; MCM9 is predominantly expressed in spermatogonial stem cells and spermatogonia in human testes.\",\n      \"method\": \"Co-immunoprecipitation in human testicular tissue; immunohistochemistry/immunofluorescence for cell-type-specific expression; HEK293T knockout and mutant overexpression HR assay\",\n      \"journal\": \"Cell death discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP of MCM9-MSH2/MLH1 interaction in human tissue and functional HR assay in KO cells; single study\",\n      \"pmids\": [\"40593474\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"MCM8/9 physically interacts with FANCD2 through the MCM8/9 core domain, independently of DNA; FANCD2 is essential for recruitment of MCM9 to ICL-induced nuclear foci, acting downstream of FANCD2 monoubiquitination; combined loss of MCM9 and FANCD2 is epistatic (no additive DNA damage), placing MCM8/9 as a downstream effector within the FA pathway for ICL repair.\",\n      \"method\": \"Co-immunoprecipitation; immunofluorescence of damage foci; MCM8/9 knockout cells; epistasis analysis by γH2AX and cell survival assays\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, foci analysis, epistasis by double KO; preprint, not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2025.08.07.669127\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"MCM9 forms a heteromeric complex with MCM8, stabilizes each other, and together function as a helicase/ATPase recruited to DNA damage sites (ICLs, DSBs) via an HROB loader and via MCM9's C-terminal BRCv motif that directly binds RAD51 to promote recombination-associated DNA synthesis downstream of the FA pathway and RAD51; MCM9 also forms a complex with MMR proteins (MSH2, MSH3, MLH1, PMS1, RFC), and its intrinsic helicase activity is required for mismatch repair; MCM9 is dispensable for bulk DNA replication in vivo but is essential for germ cell development, genome stability, and tumor suppression.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"MCM9 is a vertebrate-specific MCM-family ATPase/helicase that operates principally in DNA repair and the maintenance of genome stability rather than in bulk DNA replication [#7, #1]. It forms an obligate heteromeric complex with MCM8 in which the two subunits reciprocally stabilize each other, and this MCM8-MCM9 complex is rapidly recruited to DNA damage sites where it promotes loading of RPA and RAD51 to drive homologous recombination [#1, #3]. The complex acts downstream of the Fanconi anemia pathway and BRCA2/RAD51 to repair DNA interstrand crosslinks and to support recombination-associated DNA synthesis, with recruitment mediated by the OB-fold loader HROB and acting redundantly with the HELQ helicase [#2, #9]. MCM9 contributes its own recruitment and effector functions: a C-terminal extension carries an NLS required for nuclear import of both MCM8 and MCM9 and a variant BRC (BRCv) motif that directly binds RAD51 and recruits it to crosslink-induced damage [#11]. Independently of recombination, MCM9 assembles with mismatch repair initiation factors MSH2, MSH3, MLH1, PMS1 and the clamp loader RFC, and its intrinsic helicase activity is required for efficient mismatch repair; MCM9 chromatin loading is MSH2-dependent and in turn stimulates MLH1 recruitment, with loss causing microsatellite instability [#5]. These activities make MCM9 dispensable for cell viability but essential for germ cell development, genome stability, and tumor suppression, and loss-of-function variants in patients impair recruitment to damage sites and chromosomal break repair [#7, #8].\",\n  \"teleology\": [\n    {\n      \"year\": 2008,\n      \"claim\": \"The first functional study tested whether MCM9 participates in replication licensing, proposing it as an activating linker coupling Cdt1 to MCM2-7 loading.\",\n      \"evidence\": \"Xenopus egg extract depletion/add-back with chromatin fractionation and Co-IP\",\n      \"pmids\": [\"18657502\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-system biochemical claim later contradicted in the same extract system\", \"No in vivo test of the proposed pre-RC role\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Genetic knockout in mice directly tested the replication-licensing hypothesis and instead established MCM9 as nonessential for bulk replication but required for genome stability, germ-line maintenance, and tumor suppression.\",\n      \"evidence\": \"Constitutive/conditional knockout mice with proliferation, replication-stress, and genomic instability assays\",\n      \"pmids\": [\"21987787\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism of the genome-instability and germ-cell phenotype not resolved here\", \"Did not identify direct repair partners\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Independent knockout studies defined the MCM8-MCM9 heterocomplex as a homologous recombination factor that reciprocally stabilizes its subunits and is needed for RAD51/RPA loading and ICL repair.\",\n      \"evidence\": \"Knockout MEFs and DT40 cells with reciprocal Co-IP, chromatin recruitment, HR reporter, and FA/BRCA2 epistasis analysis\",\n      \"pmids\": [\"22771120\", \"22771115\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How the complex is recruited to damage sites unknown\", \"Helicase/ATPase activity inferred rather than directly reconstituted\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Mammalian and Xenopus studies confirmed the physical interaction, MCM8-dependent MCM9 stability, and damage-site recruitment, while a parallel egg-extract study refuted the earlier pre-RC loading role.\",\n      \"evidence\": \"Co-IP, ChIP at damage sites, HR reporter and cisplatin assays; gel filtration and chromatin fractionation in Xenopus extract\",\n      \"pmids\": [\"23401855\", \"23518502\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Reconciliation of the two conflicting egg-extract reports incomplete\", \"Recruitment factor still unidentified\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"A second, recombination-independent function was established: MCM9 helicase activity is required for mismatch repair within a complex containing MSH2/MSH3/MLH1/PMS1/RFC.\",\n      \"evidence\": \"Mcm9 knockout cells with helicase-dead rescue, Co-IP, chromatin loading and microsatellite instability assays\",\n      \"pmids\": [\"26300262\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"DNA substrate unwound during MMR not defined\", \"How MCM9 partitions between MMR and HR roles unclear\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Patient loss-of-function variants demonstrated that recruitment of MCM9 to damage sites is required for chromosomal break repair in humans.\",\n      \"evidence\": \"Patient lymphocyte DNA repair assay, splicing analysis, and immunofluorescence for MCM9 recruitment\",\n      \"pmids\": [\"25480036\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single study\", \"Did not define the molecular determinant of recruitment\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"The recruitment problem was solved by identifying HROB as an OB-fold loader that brings MCM8-MCM9 to damage, acting downstream of RAD51 redundantly with HELQ.\",\n      \"evidence\": \"Mouse knockout genetic epistasis with double mutants, foci colocalization, HR assays, and infertility phenotyping\",\n      \"pmids\": [\"31467087\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of HROB-MCM8/9 engagement unknown\", \"Division of labor between HELQ and MCM8/9 branches not fully mapped\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Domain mapping resolved how MCM9 itself contributes to nuclear import and RAD51 recruitment, identifying an NLS and a RAD51-binding BRCv motif in its C-terminal extension.\",\n      \"evidence\": \"Domain deletion/point mutants, damage-foci immunofluorescence, Co-IP of MCM9-BRCv with RAD51 in multiple cell systems\",\n      \"pmids\": [\"33539926\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of the BRCv-RAD51 interface not determined\", \"Relationship between BRCv-mediated and HROB-mediated recruitment unresolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Regulation of the complex was probed by showing HORMAD1 sequesters MCM8-MCM9 in the cytoplasm, linking aberrant expression to MMR defects in cancer.\",\n      \"evidence\": \"Co-IP, nuclear/cytoplasmic fractionation, immunofluorescence, and MLH1 chromatin binding assay\",\n      \"pmids\": [\"32647118\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Generality across tumor types not tested\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"The MMR-associated role of MCM9 was extended to human spermatogonial stem cells, tying its interactions with MSH2 and MLH1 to germ-line genome integrity.\",\n      \"evidence\": \"Co-IP in human testicular tissue, cell-type-specific immunostaining, and HR assay in knockout HEK293T cells\",\n      \"pmids\": [\"40593474\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single study\", \"Causal link between MMR defect and human fertility outcomes not established\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"A direct FANCD2-MCM8/9 interaction was reported, placing the complex as a downstream effector of FANCD2 monoubiquitination in ICL repair.\",\n      \"evidence\": \"Co-IP, damage-foci immunofluorescence, and double-knockout epistasis (preprint)\",\n      \"pmids\": [\"bio_10.1101_2025.08.07.669127\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Preprint, not yet peer-reviewed\", \"Direct binding interface and dependence on DNA require validation\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How MCM9 mechanistically partitions between its HR/ICL-repair and mismatch-repair functions, and the precise DNA substrates its helicase activity acts upon in each pathway, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No reconstituted helicase reaction defining physiological substrate\", \"No structure of the MCM8-MCM9 complex bound to DNA or partners\", \"Mechanism choosing between MMR and HR engagement unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [2, 5]},\n      {\"term_id\": \"GO:0140097\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [1, 3]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [11, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [11, 10]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [1, 3, 5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [1, 2, 3, 5, 9]},\n      {\"term_id\": \"R-HSA-1474165\", \"supporting_discovery_ids\": [7, 9, 13, 14]}\n    ],\n    \"complexes\": [\"MCM8-MCM9 helicase complex\"],\n    \"partners\": [\"MCM8\", \"RAD51\", \"HROB\", \"MSH2\", \"MLH1\", \"FANCD2\", \"HORMAD1\", \"RFC\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}